SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-037348
Filing Date
2024-03-27
Accepted
2024-03-27 17:20:24
Documents
104
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mreo-20231231.htm   iXBRL 10-K 3966962
2 EX-4.2 mreo-ex4_2.htm EX-4.2 189738
3 EX-10.30 mreo-ex10_30.htm EX-10.30 408465
4 EX-19.1 mreo-ex19_1.htm EX-19.1 126105
5 EX-23.1 mreo-ex23_1.htm EX-23.1 3629
6 EX-31.1 mreo-ex31_1.htm EX-31.1 21130
7 EX-31.2 mreo-ex31_2.htm EX-31.2 21186
8 EX-32.1 mreo-ex32_1.htm EX-32.1 6881
9 EX-32.2 mreo-ex32_2.htm EX-32.2 6849
10 EX-97.1 mreo-ex97_1.htm EX-97.1 34453
11 GRAPHIC img39675068_0.jpg GRAPHIC 505082
  Complete submission text file 0000950170-24-037348.txt   15522188

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mreo-20231231.xsd EX-101.SCH 1659736
108 EXTRACTED XBRL INSTANCE DOCUMENT mreo-20231231_htm.xml XML 2322456
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38452 | Film No.: 24791999
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)